Merck & Co. Inc. Stock Outperforms Competitors On Strong Trading Day
I'm PortAI, I can summarize articles.
Merck & Co. Inc.'s stock rose 1.30% to $100.30 on a challenging trading day, outperforming competitors like Johnson & Johnson, Pfizer, and Eli Lilly. Despite the S&P 500 and Dow Jones falling, Merck's stock marked its third consecutive day of gains, closing 5.23% below its 52-week high. Trading volume was below the 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments